Drug
Telbivudine clinical trials
Also written Sebivo, Tyzeka and LDT600.
- studies test it
- 50
- open now
- 0
- in phase 3
- 15
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
46 studies that test it; most in 2008 (6)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
- Phase 3
- 15
- Phase 4
- 27
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 22 · Other 28
Novartis Pharmaceuticals (13) · Novartis (9) · Nanfang Hospital, Southern Medical University (3) · The University of Hong Kong (2) · Third Affiliated Hospital, Sun Yat-Sen University (2) · Fuzhou General Hospital (1) · Chang Gung Memorial Hospital (1) · Asan Medical Center (1)
Often tested with
Tested in the same studies.
Lamivudine (8) · Tenofovir (5) · Adefovir dipivoxil (3) · Adefovir (3) · Valtorcitabine (1) · Peginterferon alfa-2a (1)
Studies
Open first, then newest update. How each study uses Telbivudine is read from its arms, and is right about nine times in ten.
Testing it · 50
- Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00051090Written as Telbivudine
- Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BCompletedPhase 1Novartis PharmaceuticalsNCT00907894Written as LDT600 (Telbivudine)
- Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine StudiesCompletedPhase 3Novartis PharmaceuticalsNCT00142298Written as Telbivudine (LdT)
- Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus InfectionTerminatedPhase 3Novartis PharmaceuticalsNCT02058108Written as Telbivudine
- Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis BStatus unknownPhase 4Seng Gee LimNCT02774837Written as Telbivudine
- Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedPhase 4The University of Hong KongNCT03778567Written as Telbivudine
- Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap ConceptCompletedPhase 4Novartis PharmaceuticalsNCT01379508Written as telbivudine
- TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionCompletedPhase 1/2Fuzhou General HospitalNCT02338674Written as Tenofovir and telbivudine
- The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT03468907Written as Telbivudine 600mg
- A Two-year Study of Telbivudine in HBeAg Negative HepatitisCompletedPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT01521975Written as Telbivudine, Adefovir dipivoxil
- To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)CompletedPhase 4Novartis PharmaceuticalsNCT00537537Written as Telbivudine
- An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedPhase 4Novartis PharmaceuticalsNCT00467545Written as telbivudine
- Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis BCompletedPhase 4NovartisNCT00646503Written as Telbivudine
- Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis BCompletedPhase 2NovartisNCT00128544Written as telbivudine
- Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineCompletedPhase 3Novartis PharmaceuticalsNCT00640588Written as Telbivudine
- Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedPhase 3NovartisNCT00132652Written as Telbivudine
- Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis BCompletedPhase 4Novartis PharmaceuticalsNCT00781105Written as Telbivudine
- Replacement of Lamivudine by Telbivudine to Improve Renal FunctionCompletedPhase 2/3Chang Gung Memorial HospitalNCT02447705Written as telbivudine
- Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis BCompletedPhase 3Asan Medical CenterNCT01595685Written as Telbivudine
- Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.TerminatedPhase 4National Taiwan University HospitalNCT02894554Written as Telbivudine
See all 50 studies that test Telbivudine →
As the comparator · 4 — what is tested is compared with Telbivudine
- To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis BCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT01732224Written as Tenofovir + Telbivudine
- A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownPhase 1/2Third Affiliated Hospital, Sun Yat-Sen UniversityNCT02615639Written as Telbivudine
- Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With TelbivudineTerminatedPhase 4University Hospital, Basel, SwitzerlandNCT01005238Written as Telbivudine
- The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) InfectionStatus unknownNot applicableZiv HospitalNCT01083251Written as Sebivo
Codes
What other systems call Telbivudine · ClinicalTrials.gg INT006786
- MeSH (NLM) D000077712TelbivudineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2OC4HKD3SFTELBIVUDINEConfirmed FDA, NLM, Wikidata
- RxNorm 474128Confirmed FDA, Wikidata
- Wikidata Q413621telbivudineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66584TelbivudineOne source FDA
- DrugBank DB01265One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077712 | Telbivudine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2OC4HKD3SF | TELBIVUDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 474128 | — | Confirmed FDA, Wikidata |
| Wikidata | Q413621 | telbivudine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66584 | Telbivudine | One source FDA |
| DrugBank | DB01265 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.